Search results
Results from the WOW.Com Content Network
GlySens, a biomedical technology company, is a privately owned corporation developing a long term internal continuous glucose monitor in order to effectively manage and observe glucose levels in real time. The GlySens ICGM system is the world's first surgically implanted continuous glucose monitoring system to demonstrate an 18-month ...
A common example of a commercial biosensor is the blood glucose biosensor, which uses the enzyme glucose oxidase to break blood glucose down. In doing so it first oxidizes glucose and uses two electrons to reduce the FAD (a component of the enzyme) to FADH 2. This in turn is oxidized by the electrode in a number of steps.
Fluorescent glucose biosensors are devices that measure the concentration of glucose in diabetic patients by means of sensitive protein that relays the concentration by means of fluorescence, an alternative to amperometric sension of glucose. Due to the prevalence of diabetes, it is the prime drive in the construction of fluorescent biosensors.
Enzymatic glucose biosensors use an electrode instead of O 2 to take up the electrons needed to oxidize glucose and produce an electronic current in proportion to glucose concentration. [13] This is the technology behind the disposable glucose sensor strips used by diabetics to monitor serum glucose levels. [14]
Leland C. Clark Jr. (December 4, 1918 – September 25, 2005) was an American biochemist born in Rochester, New York. [1] He is most well known as the inventor of the Clark electrode, a device used for measuring oxygen in blood, water and other liquids. [2]
Pancreatic beta cells, for example, increase oxidative metabolism as a result of a rise in blood glucose concentration, triggering secretion of insulin. [3] Glucose levels in the brain are also maintained at steady state, and glucose delivery to the brain relies on the balance between the flux of the blood brain barrier and uptake by brain ...
Bio-FETs couple a transistor device with a bio-sensitive layer that can specifically detect bio-molecules such as nucleic acids and proteins. A Bio-FET system consists of a semiconducting field-effect transistor that acts as a transducer separated by an insulator layer (e.g. SiO 2) from the biological recognition element (e.g. receptors or probe molecules) which are selective to the target ...
Electrochemical aptamer-based (E-AB) biosensors is a device that takes advantage of the electrochemical and biological properties of aptamers to take real time, in vivo measurements. An electrochemical aptamer-based (E-AB) biosensor generates an electrochemical signal in response to specific target binding in vivo [ 3 ] The signal is measured ...